Yogesh Chawla

9PUBLICATIONS
23CO-AUTHORS
Molecular targetsMetabolic medicinePredictive and prognostic markersMedical biochemistry - inorganic elements and compoundsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 07, 2026
Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ-mediated inflammatory death program.

|Jun 16, 2026
Metabolic heterogeneity and niche rewiring in bone marrow plasma cells from patients with MGUS, solitary bone plasmacytoma and multiple myeloma.

|May 04, 2026
Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review.

|Feb 27, 2026
Metabolic Heterogeneity and Niche Rewiring in Plasma Cells are Associated with Progression from MGUS to Multiple Myeloma.

Axel Walch, Guoxing Zhang, Na Sun

|Mar 31, 2025
T-Cell Engagers In Multiple Myeloma: A Clinical Review.

Ahmad Al-Jarrad, Samhar Samer Alouch, Yogesh Chawla

|Dec 12, 2024
The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review.

Adrian Alfonso Almodovar Diaz, Samhar Samer Alouch, Yogesh Chawla

Pageof 2

Frequent Collaborators

4 joint publications

Shaji Kumar

4 joint publications

Wilson I Gonsalves

3 joint publications

Akhilesh Pandey

2 joint publications

Nicholas D Sun